Hans-Georg Klingemann

Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction

Christoph Uherek, Torsten Tonn, Barbara Uherek et al. · Blood · 2002 · 258 citations · Full text

Medicine, Cancer Biology, Oncology +14

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells

Tina Müller, Christoph Uherek, Guitta Maki et al. · Cancer Immunology Immunotherapy · 2007 · 210 citations · Full text

Life Sciences, Immunology, Oncology +17

Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.

DE Reece, DA Frei-Lahr, JD Shepherd et al. · PubMed · 1991 · 191 citations

Pharmacy, Immunology, Neurology +14

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Donna Reece, Michael J. Barnett, J M Connors et al. · Journal of Clinical Oncology · 1991 · 176 citations

Medicine, Oncology, Pharmacology +16

Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.

John D. Shepherd, Lindsay Pringle, M. J. Barnett et al. · Journal of Clinical Oncology · 1991 · 167 citations

Pharmacy, Pharmacotherapy, Renal Pharmacotherapy +16